VIM::KMT2A ‐rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features
Genes, Chromosomes and Cancer · 2023
DOI: 10.1002/gcc.23138 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Shahd S Almohsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Mount Sinai Hospital & Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario…. Hauptthemen laut MEDLINE: Sarcoma, Fibrosarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The recently described K MT2A ‐rearranged sarcomas are rare emerging entities where the KMT2A gene fuses with YAP1 and, less commonly, VIM , resulting in two distinct morphologies. Unlike the sclerosing epithelioid fibrosarcoma‐like features that characterize tumors with KMT2A::YAP1 fusions, VIM::KMT2A ‐rearranged sarcomas are more uniformly cellular and lack the extensively sclerotic background seen in the former. Most tumors behave aggressively with metastases on presentation. Here, we describe the clinicopathologic and molecular findings in two additional cases of VIM::KMT2A rearranged sarcomas that arose in the deep soft tissues of adult males. Both tumors were composed of hypercellular fascicles of uniform spindle cells with pale eosinophilic cytoplasm and ovoid nuclei. The stroma had scant delicate collagen with occasional thin‐walled ectatic blood vessels and perivascular hyalinization. Immunohistochemical studies showed an unspecific staining pattern with diffuse positivity for CD99 and BCL2 and variable staining for S100 protein. RNA‐sequencing detected the presence of VIM::KMT2A gene fusion involving VIM exon 4 and KMT2A exon 2 in both cases. Sarcomas with VIM::KMT2A gene fusions seem to have sufficient morphologic features to warrant distinction from KMT2A ‐rearranged sarcomas with YAP1 partner. Without the benefit of molecular testing, these tumors pose a diagnostic challenge due to their lack of specific immunohistochemical profile and great morphologic overlap with other monomorphic spindle cell neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Mount Sinai Hospital & Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- University Musculoskeletal Oncology Unit, Sinai Health System & Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Brendan C Dickson
Zitieren
APA
Almohsen, S. S., Griffin, A. M., Dickson, B. C., & Demicco, E. G. (2023). VIM::KMT2A ‐rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23138
Vancouver
Almohsen SS, Griffin AM, Dickson BC, Demicco EG. VIM::KMT2A ‐rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23138
BibTeX
@article{Almohsen2023,
author = {Almohsen, Shahd S and Griffin, Anthony M and Dickson, Brendan C and Demicco, Elizabeth G},
title = {VIM::KMT2A ‐rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features},
journal = {Genes, Chromosomes and Cancer},
year = {2023},
doi = {10.1002/gcc.23138}
}
EUVIMED